The Prescription Drugs (Pharmacies) market in Nepal has been experiencing significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Prescription Drugs (Pharmacies) market in Nepal have been shifting towards convenience and accessibility. With the increasing urbanization and busy lifestyles, customers are seeking pharmacies that offer a wide range of prescription drugs and over-the-counter medications in one location. They also prefer pharmacies that provide personalized services, such as medication counseling and home delivery options. Additionally, customers are becoming more conscious about the quality and safety of the drugs they purchase, leading to a growing demand for pharmacies that adhere to strict quality control standards. Trends in the market indicate a rise in the number of chain pharmacies in Nepal. This trend is driven by the advantages that chain pharmacies offer, such as economies of scale, standardized operating procedures, and increased bargaining power with suppliers. Chain pharmacies are able to invest in modern technology and infrastructure, allowing them to provide a wider range of products and services to customers. Furthermore, the rise of e-commerce has also impacted the Prescription Drugs (Pharmacies) market in Nepal, with an increasing number of customers opting to purchase their medications online for convenience and cost savings. Local special circumstances in Nepal contribute to the development of the Prescription Drugs (Pharmacies) market. The country has a rapidly growing population, which translates to a larger customer base for pharmacies. Additionally, the government of Nepal has implemented policies to improve access to healthcare services, including the availability of prescription drugs. This has led to an increased demand for pharmacies and a more competitive market. Underlying macroeconomic factors also play a role in the development of the Prescription Drugs (Pharmacies) market in Nepal. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income levels. As a result, people are willing to spend more on healthcare, including prescription drugs. Furthermore, the government has been investing in healthcare infrastructure and promoting the use of generic drugs, which has led to increased availability and affordability of medications. Overall, the Prescription Drugs (Pharmacies) market in Nepal is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as the demand for convenient and accessible healthcare services increases.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
